— Know what they know.
Not Investment Advice

SNGX NASDAQ

Soligenix, Inc.
1W: -5.4% 1M: -4.7% 3M: -5.5% YTD: -67.5% 1Y: -88.4% 3Y: -94.9% 5Y: -99.8%
$0.37
+0.00 (+0.44%)
 
Weekly Expected Move ±4.0%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $5.4M mcap · 15M float · 36.03% daily turnover · Short 27% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$0 -85.8% ▼
Gross Profit
-$119K -228.5% ▼
Operating Income
-$9M -22.6% ▼
Net Income
-$8M -41.3% ▼
EPS (Diluted)
$-4.98 +60.7% ▲
EBITDA
-$9M -10.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2M$33K$250K$0$0
YoY Growth-49.0%-65.1%+15.1%-11.5%-85.8%
Cost of Revenue$2M$729K$551K$742K$119K
Gross Profit$110K-$695K-$301K-$742K-$119K
Gross Margin5.7%-2084.8%-120.3%——
R&D Expenses$15M$8M$8M$3M$5M
SG&A Expenses$4M$5M$7M$4M$4M
Operating Expenses$19M$12M$14M$7M$9M
Operating Income-$19M-$13M-$14M-$8M-$9M
Operating Margin-962.8%-39276.1%-5695.6%——
Interest Expense$11K$905K$823K$49K$0
Income Before Tax-$19M-$13M-$15M-$8M-$9M
Tax Expense-$837K-$865K-$1M-$2M-$409K
Net Income-$18M-$13M-$14M-$6M-$8M
Net Margin-916.3%-37633.0%-5519.3%——
EPS (Diluted)$-154.45$-75.06$-76.89$-12.66$-4.98
EBITDA-$18M-$12M-$14M-$8M-$9M
Shares Outstanding1145291857971794594848772M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms